Daniel Bessesen
Concepts (359)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity | 52 | 2023 | 2746 | 5.480 |
Why?
| Energy Metabolism | 28 | 2022 | 767 | 4.860 |
Why?
| Dietary Fats | 17 | 2018 | 322 | 3.260 |
Why?
| Weight Loss | 21 | 2022 | 655 | 2.740 |
Why?
| Energy Intake | 21 | 2022 | 447 | 2.590 |
Why?
| Weight Gain | 10 | 2018 | 493 | 2.160 |
Why?
| Body Weight | 15 | 2020 | 934 | 2.000 |
Why?
| Appetite | 8 | 2020 | 57 | 1.810 |
Why?
| Anti-Obesity Agents | 4 | 2019 | 49 | 1.530 |
Why?
| Exercise | 13 | 2022 | 1657 | 1.330 |
Why?
| Adiponectin | 4 | 2020 | 226 | 1.280 |
Why?
| Diet | 10 | 2023 | 1153 | 1.200 |
Why?
| Adipose Tissue | 13 | 2020 | 606 | 1.180 |
Why?
| Weight Reduction Programs | 4 | 2021 | 93 | 1.150 |
Why?
| Thinness | 6 | 2012 | 91 | 1.140 |
Why?
| Overweight | 11 | 2022 | 502 | 1.080 |
Why?
| Appetite Regulation | 3 | 2020 | 26 | 1.070 |
Why?
| Testosterone | 2 | 2020 | 351 | 1.060 |
Why?
| Adiposity | 5 | 2022 | 516 | 0.910 |
Why?
| Adult | 59 | 2023 | 31512 | 0.900 |
Why?
| Sex Characteristics | 9 | 2020 | 671 | 0.900 |
Why?
| Insulin Resistance | 9 | 2019 | 1180 | 0.890 |
Why?
| Body Composition | 14 | 2021 | 653 | 0.860 |
Why?
| Lipolysis | 2 | 2020 | 42 | 0.860 |
Why?
| Fasting | 6 | 2022 | 264 | 0.810 |
Why?
| Triglycerides | 10 | 2015 | 519 | 0.790 |
Why?
| Subcutaneous Fat | 4 | 2019 | 82 | 0.790 |
Why?
| Basal Metabolism | 5 | 2021 | 50 | 0.790 |
Why?
| Hyperphagia | 3 | 2013 | 32 | 0.760 |
Why?
| Adipogenesis | 2 | 2020 | 47 | 0.760 |
Why?
| Circadian Rhythm | 4 | 2020 | 401 | 0.750 |
Why?
| Leptin | 3 | 2020 | 231 | 0.750 |
Why?
| Postprandial Period | 6 | 2018 | 96 | 0.740 |
Why?
| Male | 61 | 2023 | 57801 | 0.690 |
Why?
| Female | 64 | 2023 | 61565 | 0.640 |
Why?
| Behavior Therapy | 4 | 2021 | 237 | 0.640 |
Why?
| Bariatric Surgery | 2 | 2019 | 166 | 0.630 |
Why?
| Humans | 89 | 2023 | 118974 | 0.620 |
Why?
| Estrogens | 1 | 2020 | 328 | 0.600 |
Why?
| Feeding Behavior | 5 | 2017 | 601 | 0.590 |
Why?
| Craving | 1 | 2016 | 33 | 0.580 |
Why?
| Fatigue | 2 | 2018 | 297 | 0.540 |
Why?
| Estradiol | 3 | 2017 | 476 | 0.540 |
Why?
| Overnutrition | 2 | 2012 | 39 | 0.530 |
Why?
| Physicians, Primary Care | 1 | 2018 | 222 | 0.530 |
Why?
| Metabolic Syndrome | 3 | 2012 | 394 | 0.530 |
Why?
| Menopause | 2 | 2017 | 266 | 0.530 |
Why?
| Endocrinology | 2 | 2015 | 68 | 0.520 |
Why?
| Lipid Metabolism | 3 | 2017 | 477 | 0.510 |
Why?
| Middle Aged | 36 | 2023 | 27617 | 0.510 |
Why?
| Mexican Americans | 1 | 2015 | 100 | 0.510 |
Why?
| Blood Glucose | 6 | 2015 | 1939 | 0.500 |
Why?
| Affect | 1 | 2016 | 240 | 0.500 |
Why?
| Hunger | 6 | 2013 | 46 | 0.490 |
Why?
| Eating | 6 | 2022 | 369 | 0.480 |
Why?
| Lipodystrophy | 2 | 2011 | 18 | 0.480 |
Why?
| Fatty Acids | 4 | 2014 | 407 | 0.480 |
Why?
| Rest | 2 | 2011 | 104 | 0.470 |
Why?
| Lipoprotein Lipase | 7 | 2010 | 68 | 0.460 |
Why?
| Diabetes Complications | 1 | 2015 | 218 | 0.450 |
Why?
| Absorptiometry, Photon | 3 | 2014 | 229 | 0.440 |
Why?
| Walking | 1 | 2016 | 415 | 0.440 |
Why?
| HIV-Associated Lipodystrophy Syndrome | 2 | 2009 | 18 | 0.440 |
Why?
| Satiation | 4 | 2010 | 24 | 0.440 |
Why?
| Delivery of Health Care | 1 | 2019 | 867 | 0.430 |
Why?
| Insulin | 5 | 2015 | 2162 | 0.420 |
Why?
| Mass Screening | 1 | 2019 | 1052 | 0.410 |
Why?
| Muscle, Skeletal | 10 | 2022 | 1515 | 0.400 |
Why?
| Cross-Over Studies | 7 | 2018 | 456 | 0.390 |
Why?
| Adipose Tissue, Brown | 1 | 2011 | 71 | 0.380 |
Why?
| Therapy, Computer-Assisted | 1 | 2011 | 60 | 0.370 |
Why?
| Fatty Acids, Nonesterified | 9 | 2019 | 167 | 0.370 |
Why?
| Calorimetry, Indirect | 6 | 2021 | 72 | 0.350 |
Why?
| Phentermine | 2 | 2019 | 10 | 0.350 |
Why?
| Cognition | 1 | 2016 | 1024 | 0.340 |
Why?
| Caloric Restriction | 4 | 2022 | 89 | 0.340 |
Why?
| Oxidation-Reduction | 9 | 2020 | 940 | 0.330 |
Why?
| Motor Activity | 3 | 2012 | 660 | 0.330 |
Why?
| Primary Health Care | 1 | 2018 | 1560 | 0.320 |
Why?
| Hormones | 2 | 2010 | 135 | 0.320 |
Why?
| Homeostasis | 1 | 2011 | 594 | 0.300 |
Why?
| Practice Guidelines as Topic | 1 | 2015 | 1440 | 0.300 |
Why?
| Ethanol | 2 | 2002 | 575 | 0.290 |
Why?
| Brain | 6 | 2017 | 2490 | 0.290 |
Why?
| Rats | 11 | 2010 | 5392 | 0.290 |
Why?
| Patient Education as Topic | 2 | 2011 | 699 | 0.290 |
Why?
| Oleic Acid | 4 | 2000 | 34 | 0.280 |
Why?
| Gastrointestinal Microbiome | 2 | 2023 | 548 | 0.270 |
Why?
| Carbon Radioisotopes | 6 | 2006 | 45 | 0.260 |
Why?
| Rats, Sprague-Dawley | 7 | 2010 | 2478 | 0.250 |
Why?
| Time Factors | 8 | 2019 | 6412 | 0.250 |
Why?
| United States | 8 | 2019 | 12555 | 0.230 |
Why?
| Hyperlipidemias | 2 | 2015 | 128 | 0.230 |
Why?
| Young Adult | 11 | 2021 | 10793 | 0.220 |
Why?
| Body Mass Index | 10 | 2022 | 2092 | 0.220 |
Why?
| Appetite Depressants | 2 | 2019 | 21 | 0.220 |
Why?
| Disease Management | 2 | 2017 | 571 | 0.210 |
Why?
| Nutritional Physiological Phenomena | 3 | 2015 | 54 | 0.200 |
Why?
| HIV Infections | 3 | 2011 | 2459 | 0.200 |
Why?
| Cross-Sectional Studies | 6 | 2022 | 4552 | 0.200 |
Why?
| Bed Rest | 1 | 2021 | 16 | 0.200 |
Why?
| alpha-Linolenic Acid | 1 | 2000 | 8 | 0.190 |
Why?
| Stearic Acids | 1 | 2000 | 14 | 0.190 |
Why?
| Premenopause | 1 | 2020 | 108 | 0.190 |
Why?
| Liver | 4 | 2006 | 1816 | 0.180 |
Why?
| Glucose Clamp Technique | 3 | 2019 | 194 | 0.180 |
Why?
| Food | 2 | 2013 | 162 | 0.180 |
Why?
| Adrenal Insufficiency | 1 | 2020 | 30 | 0.180 |
Why?
| Contraceptive Agents | 1 | 2020 | 57 | 0.180 |
Why?
| Posture | 2 | 2018 | 158 | 0.170 |
Why?
| Cardiovascular Diseases | 2 | 2022 | 1798 | 0.170 |
Why?
| Ovary | 1 | 2020 | 205 | 0.170 |
Why?
| History, 21st Century | 1 | 2019 | 170 | 0.170 |
Why?
| Animals | 17 | 2011 | 33381 | 0.170 |
Why?
| Pulmonary Gas Exchange | 4 | 2007 | 117 | 0.160 |
Why?
| Receptors, Peptide | 1 | 1998 | 24 | 0.160 |
Why?
| Safety-net Providers | 1 | 2019 | 96 | 0.160 |
Why?
| Breakfast | 2 | 2015 | 17 | 0.160 |
Why?
| Accelerometry | 2 | 2022 | 72 | 0.160 |
Why?
| Guideline Adherence | 1 | 2022 | 523 | 0.160 |
Why?
| Nutritional Status | 1 | 2000 | 300 | 0.150 |
Why?
| Cachexia | 1 | 1998 | 53 | 0.150 |
Why?
| Muscle Fibers, Skeletal | 1 | 2019 | 192 | 0.150 |
Why?
| Pilot Projects | 3 | 2022 | 1419 | 0.150 |
Why?
| Urban Population | 1 | 2019 | 409 | 0.140 |
Why?
| Human Development | 1 | 2016 | 18 | 0.140 |
Why?
| Sleep | 1 | 2022 | 660 | 0.140 |
Why?
| Counseling | 2 | 2011 | 353 | 0.140 |
Why?
| Occupational Health | 1 | 2018 | 172 | 0.140 |
Why?
| RNA, Messenger | 4 | 2017 | 2657 | 0.140 |
Why?
| Organ Specificity | 1 | 2016 | 278 | 0.140 |
Why?
| Adaptation, Physiological | 4 | 2008 | 502 | 0.140 |
Why?
| Neurons | 2 | 2017 | 1345 | 0.140 |
Why?
| Microbiota | 1 | 2023 | 656 | 0.140 |
Why?
| Rats, Zucker | 2 | 1995 | 34 | 0.140 |
Why?
| Diet Surveys | 1 | 2015 | 85 | 0.140 |
Why?
| Metabolism | 2 | 2010 | 39 | 0.130 |
Why?
| Lipectomy | 1 | 2015 | 9 | 0.130 |
Why?
| Puberty | 1 | 2016 | 144 | 0.130 |
Why?
| Endocrine System | 1 | 2015 | 22 | 0.130 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2019 | 2174 | 0.130 |
Why?
| Thigh | 1 | 2015 | 56 | 0.130 |
Why?
| Cohort Studies | 3 | 2019 | 5116 | 0.130 |
Why?
| Societies, Scientific | 1 | 2015 | 49 | 0.130 |
Why?
| Healthy Volunteers | 1 | 2015 | 201 | 0.130 |
Why?
| Phentolamine | 1 | 2014 | 17 | 0.130 |
Why?
| Terbutaline | 1 | 2014 | 9 | 0.130 |
Why?
| Adolescent | 9 | 2021 | 18480 | 0.130 |
Why?
| Sleep Apnea, Obstructive | 1 | 2018 | 231 | 0.130 |
Why?
| Magnetic Resonance Imaging | 6 | 2017 | 3174 | 0.130 |
Why?
| Postmenopause | 1 | 2016 | 305 | 0.130 |
Why?
| Sweetening Agents | 1 | 2014 | 52 | 0.120 |
Why?
| Taste | 2 | 2014 | 218 | 0.120 |
Why?
| Receptors, Estrogen | 1 | 2017 | 387 | 0.120 |
Why?
| Reward | 2 | 2017 | 209 | 0.120 |
Why?
| Exercise Test | 1 | 2016 | 551 | 0.120 |
Why?
| Carbon Dioxide | 3 | 2006 | 230 | 0.120 |
Why?
| Intra-Abdominal Fat | 2 | 2019 | 98 | 0.120 |
Why?
| Epinephrine | 1 | 2014 | 167 | 0.110 |
Why?
| Surveys and Questionnaires | 4 | 2018 | 4708 | 0.110 |
Why?
| Meals | 1 | 2014 | 101 | 0.110 |
Why?
| Kinetics | 4 | 2006 | 1624 | 0.110 |
Why?
| Cues | 2 | 2013 | 297 | 0.110 |
Why?
| Analgesics, Opioid | 1 | 2020 | 794 | 0.110 |
Why?
| Incidence | 1 | 2019 | 2424 | 0.110 |
Why?
| Rats, Wistar | 2 | 2010 | 399 | 0.110 |
Why?
| Stem Cells | 1 | 2016 | 559 | 0.110 |
Why?
| Self Report | 1 | 2015 | 699 | 0.100 |
Why?
| Adipocytes | 2 | 2016 | 199 | 0.100 |
Why?
| Tomography | 1 | 2011 | 23 | 0.100 |
Why?
| Dietary Carbohydrates | 2 | 2006 | 153 | 0.100 |
Why?
| Thermogenesis | 1 | 2011 | 43 | 0.100 |
Why?
| Cholesterol | 1 | 2012 | 373 | 0.100 |
Why?
| Colorado | 4 | 2016 | 4196 | 0.100 |
Why?
| Nutritional Sciences | 1 | 2011 | 36 | 0.100 |
Why?
| Oleic Acids | 3 | 1995 | 13 | 0.090 |
Why?
| Fat Emulsions, Intravenous | 1 | 2010 | 31 | 0.090 |
Why?
| Spinal Cord | 1 | 1993 | 367 | 0.090 |
Why?
| HIV | 1 | 2011 | 210 | 0.090 |
Why?
| Diet, Reducing | 2 | 2021 | 81 | 0.090 |
Why?
| Prognosis | 1 | 2017 | 3443 | 0.090 |
Why?
| Cell Differentiation | 1 | 2016 | 1753 | 0.090 |
Why?
| Environment | 1 | 2011 | 346 | 0.090 |
Why?
| Sex Factors | 3 | 2016 | 1781 | 0.090 |
Why?
| Treatment Outcome | 3 | 2019 | 9342 | 0.090 |
Why?
| Hypertension | 1 | 2018 | 1203 | 0.080 |
Why?
| Physician-Patient Relations | 2 | 2011 | 490 | 0.080 |
Why?
| Social Behavior | 1 | 2011 | 276 | 0.080 |
Why?
| Diet Therapy | 1 | 2008 | 38 | 0.080 |
Why?
| Physical Conditioning, Animal | 1 | 2010 | 204 | 0.080 |
Why?
| Risk Reduction Behavior | 1 | 2009 | 199 | 0.080 |
Why?
| Diet, Fat-Restricted | 1 | 2008 | 76 | 0.080 |
Why?
| Data Interpretation, Statistical | 1 | 2009 | 336 | 0.080 |
Why?
| Electronic Health Records | 3 | 2019 | 829 | 0.080 |
Why?
| Abdominal Fat | 1 | 2008 | 48 | 0.080 |
Why?
| Feasibility Studies | 2 | 2022 | 749 | 0.080 |
Why?
| Exercise Therapy | 2 | 2008 | 355 | 0.080 |
Why?
| Glucose | 2 | 2010 | 953 | 0.080 |
Why?
| Risk Factors | 4 | 2019 | 9000 | 0.080 |
Why?
| Receptor, Insulin | 1 | 2007 | 100 | 0.080 |
Why?
| Body Temperature Regulation | 1 | 2007 | 73 | 0.070 |
Why?
| Regression Analysis | 1 | 2009 | 983 | 0.070 |
Why?
| Palmitates | 1 | 2006 | 19 | 0.070 |
Why?
| Breeding | 1 | 2006 | 56 | 0.070 |
Why?
| Forecasting | 1 | 2008 | 353 | 0.070 |
Why?
| Brain Mapping | 1 | 2010 | 532 | 0.070 |
Why?
| Intestinal Absorption | 1 | 2006 | 104 | 0.070 |
Why?
| Myocardium | 1 | 1991 | 970 | 0.070 |
Why?
| Biomarkers | 1 | 2015 | 3588 | 0.070 |
Why?
| Phenotype | 2 | 2006 | 3003 | 0.070 |
Why?
| Aged | 7 | 2018 | 19657 | 0.060 |
Why?
| Clinical Trials as Topic | 1 | 2009 | 969 | 0.060 |
Why?
| Prospective Studies | 2 | 2020 | 6471 | 0.060 |
Why?
| Lithium | 1 | 2004 | 41 | 0.060 |
Why?
| Enteral Nutrition | 1 | 2006 | 170 | 0.060 |
Why?
| Prevalence | 2 | 2018 | 2326 | 0.060 |
Why?
| Image Processing, Computer-Assisted | 3 | 2014 | 709 | 0.060 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 341 | 0.060 |
Why?
| Models, Biological | 1 | 2011 | 1715 | 0.060 |
Why?
| Area Under Curve | 2 | 2015 | 296 | 0.060 |
Why?
| Aging | 2 | 2017 | 1670 | 0.060 |
Why?
| Up-Regulation | 1 | 2006 | 872 | 0.050 |
Why?
| Time | 1 | 2002 | 77 | 0.050 |
Why?
| Blood Pressure | 3 | 2019 | 1664 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2003 | 233 | 0.050 |
Why?
| Statistics as Topic | 2 | 2014 | 307 | 0.050 |
Why?
| Waist Circumference | 1 | 2021 | 130 | 0.050 |
Why?
| Metabolic Networks and Pathways | 1 | 2022 | 176 | 0.050 |
Why?
| Patient Compliance | 1 | 2004 | 537 | 0.050 |
Why?
| Digestive System | 1 | 2000 | 30 | 0.050 |
Why?
| Radioisotope Dilution Technique | 1 | 2000 | 14 | 0.050 |
Why?
| Infant, Newborn | 1 | 2011 | 5255 | 0.050 |
Why?
| Pregnancy | 2 | 2011 | 5691 | 0.050 |
Why?
| Administration, Oral | 1 | 2002 | 756 | 0.040 |
Why?
| Age Factors | 2 | 2007 | 2995 | 0.040 |
Why?
| Cardiorespiratory Fitness | 1 | 2019 | 39 | 0.040 |
Why?
| Tissue Distribution | 1 | 2000 | 334 | 0.040 |
Why?
| Feces | 1 | 2021 | 396 | 0.040 |
Why?
| Leisure Activities | 1 | 2018 | 27 | 0.040 |
Why?
| Uncoupling Agents | 1 | 1998 | 2 | 0.040 |
Why?
| Cyclobutanes | 1 | 1998 | 7 | 0.040 |
Why?
| Hydrocortisone | 1 | 2020 | 273 | 0.040 |
Why?
| Primary Cell Culture | 1 | 2019 | 155 | 0.040 |
Why?
| Melanins | 1 | 1998 | 22 | 0.040 |
Why?
| Time-to-Treatment | 1 | 2019 | 149 | 0.040 |
Why?
| Gene Expression Regulation | 2 | 2019 | 2445 | 0.040 |
Why?
| Food Analysis | 1 | 2017 | 18 | 0.040 |
Why?
| Oxygen | 2 | 2014 | 854 | 0.040 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2022 | 1244 | 0.040 |
Why?
| Cerebral Cortex | 2 | 2013 | 416 | 0.040 |
Why?
| Cause of Death | 1 | 2019 | 380 | 0.040 |
Why?
| Mortality | 1 | 2019 | 299 | 0.040 |
Why?
| Dietary Fiber | 1 | 1997 | 44 | 0.040 |
Why?
| Interdisciplinary Communication | 1 | 2018 | 191 | 0.040 |
Why?
| Alcohol Drinking | 2 | 2000 | 652 | 0.040 |
Why?
| Cell Size | 1 | 2016 | 86 | 0.040 |
Why?
| Proteomics | 1 | 2022 | 876 | 0.040 |
Why?
| Predictive Value of Tests | 1 | 2021 | 1868 | 0.040 |
Why?
| Combined Modality Therapy | 1 | 2019 | 1166 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2019 | 409 | 0.040 |
Why?
| Social Class | 1 | 2018 | 218 | 0.040 |
Why?
| Hyperinsulinism | 1 | 1997 | 107 | 0.030 |
Why?
| Mitochondria | 1 | 2022 | 786 | 0.030 |
Why?
| Apolipoproteins E | 1 | 1996 | 90 | 0.030 |
Why?
| Athletes | 1 | 2019 | 353 | 0.030 |
Why?
| Subcutaneous Fat, Abdominal | 1 | 2015 | 16 | 0.030 |
Why?
| Cell Proliferation | 2 | 2016 | 2275 | 0.030 |
Why?
| Chylomicrons | 1 | 1995 | 7 | 0.030 |
Why?
| Oxidative Stress | 1 | 2022 | 1178 | 0.030 |
Why?
| Phosphorylation | 3 | 2008 | 1633 | 0.030 |
Why?
| Palmitic Acid | 1 | 2014 | 38 | 0.030 |
Why?
| Societies, Medical | 1 | 2018 | 703 | 0.030 |
Why?
| Taste Perception | 1 | 2014 | 28 | 0.030 |
Why?
| Disease Models, Animal | 2 | 2008 | 3730 | 0.030 |
Why?
| Muscles | 1 | 1995 | 333 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2021 | 2874 | 0.030 |
Why?
| Norepinephrine | 1 | 2014 | 212 | 0.030 |
Why?
| Social Control, Informal | 1 | 2013 | 19 | 0.030 |
Why?
| Pleasure | 1 | 2013 | 18 | 0.030 |
Why?
| Blotting, Northern | 1 | 1993 | 194 | 0.030 |
Why?
| Logistic Models | 1 | 2018 | 1901 | 0.030 |
Why?
| In Situ Hybridization | 1 | 1993 | 311 | 0.030 |
Why?
| Lipids | 1 | 1996 | 607 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2019 | 1597 | 0.030 |
Why?
| Proteins | 1 | 1998 | 938 | 0.030 |
Why?
| Research Design | 1 | 2018 | 969 | 0.030 |
Why?
| Baculoviridae | 1 | 1991 | 46 | 0.030 |
Why?
| Heparin | 1 | 1993 | 230 | 0.030 |
Why?
| Immunohistochemistry | 2 | 1993 | 1691 | 0.030 |
Why?
| Rats, Inbred Strains | 1 | 1991 | 394 | 0.020 |
Why?
| Breast | 1 | 1991 | 140 | 0.020 |
Why?
| Heart Rate | 1 | 2014 | 729 | 0.020 |
Why?
| Evidence-Based Medicine | 1 | 2015 | 693 | 0.020 |
Why?
| Lactones | 1 | 2010 | 57 | 0.020 |
Why?
| Myoblasts | 1 | 2010 | 75 | 0.020 |
Why?
| Prefrontal Cortex | 1 | 2013 | 275 | 0.020 |
Why?
| Lipoproteins | 1 | 2010 | 162 | 0.020 |
Why?
| Mice | 3 | 2010 | 15520 | 0.020 |
Why?
| Hippocampus | 1 | 1993 | 735 | 0.020 |
Why?
| Acetyl-CoA Carboxylase | 1 | 2008 | 38 | 0.020 |
Why?
| Glycogen | 1 | 2008 | 59 | 0.020 |
Why?
| Transfection | 1 | 2010 | 888 | 0.020 |
Why?
| Office Visits | 1 | 2008 | 83 | 0.020 |
Why?
| Hyperplasia | 1 | 2008 | 170 | 0.020 |
Why?
| Blotting, Western | 1 | 2010 | 1194 | 0.020 |
Why?
| Anthropometry | 1 | 2008 | 194 | 0.020 |
Why?
| Apoptosis | 1 | 2016 | 2484 | 0.020 |
Why?
| Photic Stimulation | 1 | 2007 | 204 | 0.020 |
Why?
| Hypothalamus | 1 | 2007 | 155 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2018 | 6561 | 0.020 |
Why?
| Glucose Tolerance Test | 1 | 2008 | 368 | 0.020 |
Why?
| Visual Perception | 1 | 2007 | 141 | 0.020 |
Why?
| Down-Regulation | 1 | 2008 | 627 | 0.020 |
Why?
| Protein Subunits | 1 | 2006 | 211 | 0.020 |
Why?
| Recurrence | 1 | 2008 | 975 | 0.020 |
Why?
| Citrates | 1 | 2004 | 48 | 0.020 |
Why?
| Bicycling | 1 | 2005 | 77 | 0.020 |
Why?
| Respiration | 1 | 2005 | 183 | 0.020 |
Why?
| Cell Line | 1 | 2010 | 2707 | 0.020 |
Why?
| DNA-Binding Proteins | 1 | 1991 | 1346 | 0.020 |
Why?
| Analysis of Variance | 1 | 2007 | 1293 | 0.020 |
Why?
| Postoperative Complications | 1 | 2015 | 2235 | 0.020 |
Why?
| Transcription Factors | 1 | 1991 | 1570 | 0.010 |
Why?
| Retrospective Studies | 1 | 2019 | 12978 | 0.010 |
Why?
| Health Behavior | 1 | 2008 | 720 | 0.010 |
Why?
| Double-Blind Method | 1 | 2004 | 1687 | 0.010 |
Why?
| Placebos | 1 | 1998 | 202 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2005 | 2674 | 0.010 |
Why?
| Dietary Fats, Unsaturated | 1 | 1997 | 22 | 0.010 |
Why?
| Child | 1 | 2016 | 19129 | 0.010 |
Why?
| Dietary Proteins | 1 | 1997 | 130 | 0.010 |
Why?
| Perineum | 1 | 1955 | 29 | 0.010 |
Why?
| Cholesterol, HDL | 1 | 1996 | 198 | 0.010 |
Why?
| DNA Primers | 1 | 1996 | 533 | 0.010 |
Why?
| Pelvis | 1 | 1955 | 92 | 0.010 |
Why?
| Cholesterol, LDL | 1 | 1996 | 316 | 0.010 |
Why?
| Cells, Cultured | 2 | 1991 | 4077 | 0.010 |
Why?
| Alleles | 1 | 1996 | 832 | 0.010 |
Why?
| Wound Healing | 1 | 1955 | 270 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1996 | 1012 | 0.010 |
Why?
| Polymorphism, Genetic | 1 | 1996 | 642 | 0.010 |
Why?
| Chemical Fractionation | 1 | 1991 | 29 | 0.010 |
Why?
| Base Sequence | 1 | 1996 | 2159 | 0.010 |
Why?
| Brachial Plexus Block | 1 | 1950 | 4 | 0.010 |
Why?
| Nucleic Acid Hybridization | 1 | 1991 | 193 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 1996 | 2871 | 0.010 |
Why?
| Brachial Plexus | 1 | 1950 | 29 | 0.010 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 1991 | 144 | 0.010 |
Why?
| Genetic Vectors | 1 | 1991 | 302 | 0.010 |
Why?
| Genotype | 1 | 1996 | 1882 | 0.010 |
Why?
| Lactation | 1 | 1991 | 160 | 0.010 |
Why?
| Hot Temperature | 1 | 1991 | 334 | 0.010 |
Why?
| Smoking | 1 | 1997 | 1487 | 0.010 |
Why?
| Neurosurgical Procedures | 1 | 1950 | 164 | 0.010 |
Why?
| Cell Nucleus | 1 | 1991 | 580 | 0.010 |
Why?
| Recombinant Proteins | 1 | 1991 | 1308 | 0.000 |
Why?
| Wounds and Injuries | 1 | 1955 | 772 | 0.000 |
Why?
| Gene Expression | 1 | 1991 | 1489 | 0.000 |
Why?
| Transcription, Genetic | 1 | 1991 | 1323 | 0.000 |
Why?
|
|
Bessesen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|